{"id":"W311717631","doi":"10.1007/s00262-002-0343-x","title":"A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma","year":2003,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Calicheamicin; Immunoconjugate; Medicine; Ovarian cancer; Internal medicine; Ovarian carcinoma; Gastroenterology; Adverse effect; Oncology; Cytotoxic T cell; Monoclonal antibody; Cancer; Myeloid leukemia; Antibody; Immunology; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001225381,0.0009587548,0.002017134,0.0003762132,0.0005850019,0.0007740131,0.0005749325,0.001304004,0.001821629],"category_scores_gemma":[0.0009478005,0.0005302777,0.0008606255,0.0003703751,0.0008852299,0.00066488,0.0003454888,0.002498844,0.0005494789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001057751,"about_ca_system_score_gemma":0.001274773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001889467,"about_ca_topic_score_gemma":0.003048174,"domain_scores_codex":[0.9995604,0.0002139549,0.00001803102,0.00006466595,0.00004066221,0.0001022963],"domain_scores_gemma":[0.9994854,0.000108986,0.00005799036,0.00006519578,0.00002726474,0.0002551645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5033233,0.1208393,0.02280393,0.0006512915,0.001216545,0.00189119,0.001209809,0.007099854,0.1455398,0.0006543487,0.003128505,0.1916422],"study_design_scores_gemma":[0.2628774,0.6986517,0.02163905,0.00002025636,0.0003896424,0.001118748,0.0001385916,0.002202715,0.009829536,0.0002039975,0.002892767,0.00003558298],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974685,0.0005003272,0.0002710329,0.0002176378,0.00004781183,0.0006895539,0.0001474272,0.00003147042,0.0006263196],"genre_scores_gemma":[0.996519,0.0005476094,0.0005919079,0.0002795046,0.00007083622,0.0005845097,0.0004571788,0.00001391997,0.0009356702],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002017134,"threshold_uncertainty_score":0.007674515,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01381652151134338,"score_gpt":0.2800756681982798,"score_spread":0.2662591466869364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}